Stay updated on Nivolumab +/- Ipilimumab in NECs Clinical Trial
Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.

Latest updates to the Nivolumab +/- Ipilimumab in NECs Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, representing an internal update to the page version rather than changes to the study details.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s revision tag was updated from v3.6.2 to v3.6.3, signaling a maintenance or content update to the study page without altering its substantive details.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, representing a minor update to the page's versioning. This update does not imply a major change to the content or functionality.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now indicates that enrollment is closed for the study, and it adds new guidance sections to help users understand and join studies, while updating the Intervention/Treatment header formatting and revision version.SummaryDifference0.4%

- Check60 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a recent maintenance update to the site. The study details and displayed information remain the same.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.5.4 was added, replacing v3.5.3. This signals a small update to the page metadata rather than a substantive content change.SummaryDifference0.1%

Stay in the know with updates to Nivolumab +/- Ipilimumab in NECs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.